We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
MainStreet Bancshares
MNSB
$172M
| $147K | ﹤0.01% |
7,135
+340
| +5% | +$7.77K |
|
3127
Fossil Group
FOSL
$318M
| $146K | ﹤0.01% |
70,910
-462
| -0.6% | -$1.08K |
|
3128
RGC Resources
RGCO
$228M
| $146K | ﹤0.01% |
8,432
+436
| +5% | +$8.17K |
|
3129
Mayville Engineering Co
MEC
$617M
| $146K | ﹤0.01% |
13,268
+518
| +4% | +$5.98K |
|
|
CARM
3130
DELISTED
Carisma Therapeutics
CARM
| $145K | ﹤0.01% |
34,363
+2,797
| +9% | +$17.7K |
|
3131
Criteo S.A. Ordinary Shares
CRTO
$923M
| $145K | ﹤0.01% |
4,977
+75
| +2% | +$2.3K |
|
3132
Traeger
COOK
$172M
| $145K | ﹤0.01% |
1,059
-5
| -0.5% | -$1.06K |
|
|
B
3133
Barrick Mining
B
$73.2B
| $144K | ﹤0.01% |
9,906
+295
| +3% | +$4.84K |
|
3134
InfuSystem Holdings
INFU
$249M
| $144K | ﹤0.01% |
14,909
+963
| +7% | +$9.86K |
|
3135
Methanex
MEOH
$4.12B
| $144K | ﹤0.01% |
3,187
+5
| +0.2% | +$214 |
|
3136
Urban One Class D
UONEK
$23.8M
| $144K | ﹤0.01% |
2,853
+126
| +5% | +$6.87K |
|
3137
Pioneer Bancorp
PBFS
$434M
| $143K | ﹤0.01% |
16,754
-47
| -0.3% | -$435 |
|
3138
Cadiz
CDZI
$291M
| $143K | ﹤0.01% |
43,150
+3,000
| +7% | +$11.5K |
|
|
JOYY
3139
JOYY Inc
JOYY
$3.75B
| $142K | ﹤0.01% |
3,734
+165
| +5% | +$5.72K |
|
3140
Lexicon Pharmaceuticals
LXRX
$1.1B
| $142K | ﹤0.01% |
130,291
-9,456
| -7% | -$16.6K |
|
3141
Chemung Financial Corp
CHMG
$392M
| $142K | ﹤0.01% |
3,585
+205
| +6% | +$8.24K |
|
|
LOGC
3142
DELISTED
ContextLogic
LOGC
| $141K | ﹤0.01% |
32,072
-1,595
| -5% | -$9.93K |
|
3143
Annexon
ANNX
$886M
| $141K | ﹤0.01% |
59,710
+4,680
| +9% | +$14.2K |
|
3144
Choiceone Financial
COFS
$510M
| $140K | ﹤0.01% |
7,153
+376
| +6% | +$8.76K |
|
|
SKYT
3145
DELISTED
SkyWater Technology
SKYT
| $140K | ﹤0.01% |
23,234
-278
| -1% | -$2.11K |
|
|
PHLT
3146
DELISTED
Performant Healthcare Inc
PHLT
| $139K | ﹤0.01% |
61,725
+3,633
| +6% | +$9.22K |
|
|
CCRD
3147
DELISTED
CoreCard
CCRD
| $139K | ﹤0.01% |
6,965
+392
| +6% | +$8.73K |
|
3148
Heron Therapeutics
HRTX
$92.9M
| $139K | ﹤0.01% |
135,202
-2,216
| -2% | -$3.15K |
|
3149
Velocity Financial
VEL
$729M
| $139K | ﹤0.01% |
12,311
+525
| +4% | +$6.38K |
|
3150
BCE
BCE
$21.2B
| $139K | ﹤0.01% |
3,638
+5
| +0.1% | +$210 |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.